The antihypertensive compounds hydralazine, dihydralazine and cadralazine and their metabolites inhibit myeloperoxidase activity as measured by chemiluminescence.

Authors :: Nässberger L
Source :: Biochemical pharmacology [Biochem Pharmacol] 1991 Oct 09; Vol. 42 (9), pp. 1844-7.
Publication Year :: 1991

Subjects :: Binding Sites
Dose-Response Relationship, Drug
Luminescent Measurements
Magnetic Resonance Spectroscopy
Peroxidase isolation & purification
Structure-Activity Relationship
Antihypertensive Agents pharmacology
Dihydralazine pharmacology
Hydralazine pharmacology
Peroxidase antagonists & inhibitors
Pyridazines pharmacology

Full Text Access

Tools